MariMed Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 38.9 million compared to USD 35.83 million a year ago. Net loss was USD 10.17 million compared to net income of USD 4.75 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to basic earnings per share from continuing operations of USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.03 compared to diluted earnings per share from continuing operations of USD 0.01 a year ago.

For the full year, the company reported sales was USD 148.6 million compared to USD 134.01 million a year ago. Net loss was USD 16.03 million compared to net income of USD 13.47 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to basic earnings per share from continuing operations of USD 0.04 a year ago. Diluted loss per share from continuing operations was USD 0.04 compared to diluted earnings per share from continuing operations of USD 0.04 a year ago.